TRUVESIC Trademark

Trademark Overview


On Tuesday, May 16, 2023, a trademark application was filed for TRUVESIC with the United States Patent and Trademark Office. The USPTO has given the TRUVESIC trademark a serial number of 97939161. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, June 12, 2024. This trademark is owned by CG Oncology, Inc.. The TRUVESIC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders, immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders
truvesic

General Information


Serial Number97939161
Word MarkTRUVESIC
Filing DateTuesday, May 16, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, June 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2024

Trademark Statements


Goods and ServicesPharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders, immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 15, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCG Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Party NameCG Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events


Event DateEvent Description
Thursday, February 8, 2024ASSIGNED TO EXAMINER
Friday, May 19, 2023NEW APPLICATION ENTERED
Thursday, June 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 2, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, March 4, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, March 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 12, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 12, 2024SOU EXTENSION 1 FILED
Wednesday, June 12, 2024SOU EXTENSION 1 GRANTED